Posted On: 12/09/2013 8:01:10 PM
Post# of 94266
$HEB News
Wednesday's biggest gaining and declining stocks 5:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 6:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 6:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 5:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 8:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 12:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 12:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 12:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 5:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 12:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 9:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 2:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 5:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 10:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 3:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 3:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 3:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 8:39 a.m. May 24, 2006 - Tomi Kilgore
Drug stocks end mixed; Serono dives on sale plan 3:40 p.m. April 10, 2006 - Val Brickates Kennedy
10-Q: HEMISPHERX BIOPHARMA INC 4:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Hemispherx Announces Alpha-N3 is Active Compared to Two H7N9 Virus Types 6:04 a.m. Sept. 12, 2013 - benzinga.com
Hemispherx Reports Biosecurity Program for Reduction of Pandemic Flu Threat 5:31 a.m. Sept. 12, 2013 - benzinga.com
Hemispherx Reports Biosecurity Program to Potentially Reduce Pandemic Flu Threat 6:05 a.m. Aug. 26, 2013 - benzinga.com
10-Q: HEMISPHERX BIOPHARMA INC 3:15 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 2:21 p.m. May 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotechs Ramping Up On China's Avian Flu Outbreak 1:42 a.m. April 8, 2013 - Seeking Alpha
10-K: HEMISPHERX BIOPHARMA INC 2:06 p.m. March 18, 2013 - Edgar Online - (EDG = 10Q, 10K)
Hemispherx Wins Broad Treatment Expansion for Alferon N Injection in Argentina 7:08 a.m. March 4, 2013 - benzinga.com
Biotech Movers: A Doubler for Opexa 2:30 a.m. Feb. 11, 2013 - InvestorPlace.com
Hemispherx Biopharma Says FDA Panel Voted 9-4 Against Ampligen Effocacy 2:01 p.m. Dec. 21, 2012 - benzinga.com
2 Biotech Stocks That Could Be Prime Candidates For The Short Seller 11:18 a.m. Dec. 21, 2012 - Seeking Alpha
Hemispherx BioPharma Soars Then Plunges as FDA Panel Votes Against Ampligen Approval 5:09 p.m. Dec. 20, 2012 - benzinga.com
Amgen Licenses ImmunoGen Tech, Hemispherx Drug Questioned by FDA: Healthcare Business Recap 3:25 p.m. Dec. 19, 2012 - Wall St. Cheat Sheet
Stock Watch Wednesday, 19 December 9:24 a.m. Dec. 19, 2012 - Seeking Alpha
Hemispherx Faces FDA Day 6:51 a.m. Dec. 19, 2012 - Seeking Alpha
Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration 7:55 a.m. Dec. 18, 2012 - Seeking Alpha
Hemispherx's Ampligen Is Unlikely To Receive FDA Approval 5:46 a.m. Dec. 18, 2012 - Seeking Alpha
Ampligen: The Political Calculus Has Changed 5:37 a.m. Dec. 12, 2012 - Seeking Alpha
Tuesday's Small-Cap Biopharma Catalyst Trade List 8:45 a.m. Dec. 11, 2012 - Seeking Alpha
FDA Authorizes Expansion of Ampligen/FluMist Intranasal Clinical Trial Designed to Elicit Potential Protection Against Many Pre-Pandemic Influenza Viruses 8:00 a.m. Today - GlobeNewswire
Hemispherx Biopharma Appoints New Chief Financial and Chief Accounting Officers 7:30 a.m. Dec. 4, 2013 - GlobeNewswire
Hemispherx Biopharma and the University of Pittsburgh Collaborate on a Novel Chemokine-Modulatory Program for Cancer Immunotherapies With Ampligen(R) as a Key Component 7:30 a.m. Dec. 2, 2013 - GlobeNewswire
Hemispherx Biopharma Sponsors Chronic Fatigue Syndrome Conference at Mount Sinai Medical Center in New York 8:00 a.m. Nov. 19, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2013 4:25 p.m. Nov. 8, 2013 - GlobeNewswire
Hemispherx Biopharma Reports on Annual Stockholder Meeting 12:10 p.m. Oct. 18, 2013 - GlobeNewswire
Hemispherx Biopharma's 2013 Stockholder Annual Meeting Proposal 4 Removed From Stockholder Consideration 12:47 p.m. Oct. 3, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Launches An Investigation Against Hemispherx Biopharma, Inc. (HEB) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors 3:00 p.m. Sept. 20, 2013 - BusinessWire
Hemispherx Biopharma's 2013 Stockholder Annual Meeting Set 3:30 p.m. Sept. 18, 2013 - GlobeNewswire
Natural Human Interferon (Alpha-n3) is Active Against Both Wild-Type and Oseltamivir Resistant Avian-Origin Influenza A (H7N9) Virus 7:00 a.m. Sept. 12, 2013 - GlobeNewswire
Hemispherx Announces Initial Test Results in Biosecurity/Biodefense Arena 6:45 a.m. Sept. 12, 2013 - GlobeNewswire
Hemispherx Announces Biosecurity Program to Potentially Reduce Pandemic Influenza Threat 6:30 a.m. Sept. 12, 2013 - GlobeNewswire
Director of the U.S. Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Professor J. Richt, DVM, Ph.D., to Present Programs to Potentially Reduce Pandemic Influenza Spread 7:25 a.m. Sept. 4, 2013 - GlobeNewswire
Hemispherx Biopharma to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 3:05 p.m. Sept. 3, 2013 - GlobeNewswire
Hemispherx Announces Biosecurity Program to Potentially Reduce Pandemic Influenza Threat 7:00 a.m. Aug. 26, 2013 - GlobeNewswire
Director of the U.S. Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Professor J. Richt, DVM, Ph.D., to Present Programs to Reduce - Influenza Spread 10:22 a.m. Aug. 20, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended June 30, 2013 3:24 p.m. Aug. 9, 2013 - GlobeNewswire
Hemispherx Biopharma Appoints Peter W. Rodino III, Esq. to the Board of Directors and to Serve as Chairman of the Company's Audit Committee 7:12 a.m. July 29, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2013 2:54 p.m. May 8, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2012 2:24 p.m. March 18, 2013 - GlobeNewswire
Wednesday's biggest gaining and declining stocks 5:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 6:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 6:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 5:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 8:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 12:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 12:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 12:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 5:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 12:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 9:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 2:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 5:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 10:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 3:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 3:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 3:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 8:39 a.m. May 24, 2006 - Tomi Kilgore
Drug stocks end mixed; Serono dives on sale plan 3:40 p.m. April 10, 2006 - Val Brickates Kennedy
10-Q: HEMISPHERX BIOPHARMA INC 4:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Hemispherx Announces Alpha-N3 is Active Compared to Two H7N9 Virus Types 6:04 a.m. Sept. 12, 2013 - benzinga.com
Hemispherx Reports Biosecurity Program for Reduction of Pandemic Flu Threat 5:31 a.m. Sept. 12, 2013 - benzinga.com
Hemispherx Reports Biosecurity Program to Potentially Reduce Pandemic Flu Threat 6:05 a.m. Aug. 26, 2013 - benzinga.com
10-Q: HEMISPHERX BIOPHARMA INC 3:15 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 2:21 p.m. May 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotechs Ramping Up On China's Avian Flu Outbreak 1:42 a.m. April 8, 2013 - Seeking Alpha
10-K: HEMISPHERX BIOPHARMA INC 2:06 p.m. March 18, 2013 - Edgar Online - (EDG = 10Q, 10K)
Hemispherx Wins Broad Treatment Expansion for Alferon N Injection in Argentina 7:08 a.m. March 4, 2013 - benzinga.com
Biotech Movers: A Doubler for Opexa 2:30 a.m. Feb. 11, 2013 - InvestorPlace.com
Hemispherx Biopharma Says FDA Panel Voted 9-4 Against Ampligen Effocacy 2:01 p.m. Dec. 21, 2012 - benzinga.com
2 Biotech Stocks That Could Be Prime Candidates For The Short Seller 11:18 a.m. Dec. 21, 2012 - Seeking Alpha
Hemispherx BioPharma Soars Then Plunges as FDA Panel Votes Against Ampligen Approval 5:09 p.m. Dec. 20, 2012 - benzinga.com
Amgen Licenses ImmunoGen Tech, Hemispherx Drug Questioned by FDA: Healthcare Business Recap 3:25 p.m. Dec. 19, 2012 - Wall St. Cheat Sheet
Stock Watch Wednesday, 19 December 9:24 a.m. Dec. 19, 2012 - Seeking Alpha
Hemispherx Faces FDA Day 6:51 a.m. Dec. 19, 2012 - Seeking Alpha
Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration 7:55 a.m. Dec. 18, 2012 - Seeking Alpha
Hemispherx's Ampligen Is Unlikely To Receive FDA Approval 5:46 a.m. Dec. 18, 2012 - Seeking Alpha
Ampligen: The Political Calculus Has Changed 5:37 a.m. Dec. 12, 2012 - Seeking Alpha
Tuesday's Small-Cap Biopharma Catalyst Trade List 8:45 a.m. Dec. 11, 2012 - Seeking Alpha
FDA Authorizes Expansion of Ampligen/FluMist Intranasal Clinical Trial Designed to Elicit Potential Protection Against Many Pre-Pandemic Influenza Viruses 8:00 a.m. Today - GlobeNewswire
Hemispherx Biopharma Appoints New Chief Financial and Chief Accounting Officers 7:30 a.m. Dec. 4, 2013 - GlobeNewswire
Hemispherx Biopharma and the University of Pittsburgh Collaborate on a Novel Chemokine-Modulatory Program for Cancer Immunotherapies With Ampligen(R) as a Key Component 7:30 a.m. Dec. 2, 2013 - GlobeNewswire
Hemispherx Biopharma Sponsors Chronic Fatigue Syndrome Conference at Mount Sinai Medical Center in New York 8:00 a.m. Nov. 19, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2013 4:25 p.m. Nov. 8, 2013 - GlobeNewswire
Hemispherx Biopharma Reports on Annual Stockholder Meeting 12:10 p.m. Oct. 18, 2013 - GlobeNewswire
Hemispherx Biopharma's 2013 Stockholder Annual Meeting Proposal 4 Removed From Stockholder Consideration 12:47 p.m. Oct. 3, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Launches An Investigation Against Hemispherx Biopharma, Inc. (HEB) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors 3:00 p.m. Sept. 20, 2013 - BusinessWire
Hemispherx Biopharma's 2013 Stockholder Annual Meeting Set 3:30 p.m. Sept. 18, 2013 - GlobeNewswire
Natural Human Interferon (Alpha-n3) is Active Against Both Wild-Type and Oseltamivir Resistant Avian-Origin Influenza A (H7N9) Virus 7:00 a.m. Sept. 12, 2013 - GlobeNewswire
Hemispherx Announces Initial Test Results in Biosecurity/Biodefense Arena 6:45 a.m. Sept. 12, 2013 - GlobeNewswire
Hemispherx Announces Biosecurity Program to Potentially Reduce Pandemic Influenza Threat 6:30 a.m. Sept. 12, 2013 - GlobeNewswire
Director of the U.S. Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Professor J. Richt, DVM, Ph.D., to Present Programs to Potentially Reduce Pandemic Influenza Spread 7:25 a.m. Sept. 4, 2013 - GlobeNewswire
Hemispherx Biopharma to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 3:05 p.m. Sept. 3, 2013 - GlobeNewswire
Hemispherx Announces Biosecurity Program to Potentially Reduce Pandemic Influenza Threat 7:00 a.m. Aug. 26, 2013 - GlobeNewswire
Director of the U.S. Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Professor J. Richt, DVM, Ph.D., to Present Programs to Reduce - Influenza Spread 10:22 a.m. Aug. 20, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended June 30, 2013 3:24 p.m. Aug. 9, 2013 - GlobeNewswire
Hemispherx Biopharma Appoints Peter W. Rodino III, Esq. to the Board of Directors and to Serve as Chairman of the Company's Audit Committee 7:12 a.m. July 29, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2013 2:54 p.m. May 8, 2013 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2012 2:24 p.m. March 18, 2013 - GlobeNewswire
(0)
(0)
